Medytox Derma Cosmetic Brand 'Neuraderm' Signs Exclusive Supply Agreement with Greece's 'AMG'

Medytox, a biopharmaceutical company, announced on June 8 that its neuroderma cosmetic brand 'Neuraderm (NEURADERM)' has signed an exclusive supply agreement with the Greek medical device and cosmetic distribution company 'AMG (Asklipios Medical Group)'.

Medytox's neuroderma cosmetic brand 'Neuraderm (NEURADERM)' product. Medytox

Through this agreement, 'Neuraderm' will expand its presence to seven European countries, including Greece, Italy, Spain, and France, following its entry into four Asian countries—Japan, Vietnam, Indonesia, and Hong Kong. Medytox plans to leverage AMG's distribution network to launch its products across various online and offline sales channels and to gradually strengthen its position in the European market.

Last month, AMG showcased Medytox's 'Neuraderm' product lineup at the 'Beauty Macedonia 2026', the largest beauty expo in Greece, where the lineup received positive reviews from global buyers and consumers, confirming its competitiveness in the local market.

A Medytox representative stated, "This exclusive supply agreement with AMG will serve as a strategic foundation for the global expansion of Neuraderm," adding, "We will focus our resources so that Neuraderm can become a leading global brand representing K-Derma cosmetics."

Meanwhile, Neuraderm is a neuroderma cosmetic brand developed by Medytox, based on over 20 years of accumulated research and development in neuroscience and dermatology. The brand is focused on enhancing the fundamental quality of skin, such as improving wrinkles, increasing elasticity, and strengthening the skin barrier. Its representative products include 'Neuraderm Core Time Ampoule', 'Core Time Synergy Essence', and 'Derma Cream'. Recently, the company renewed and relaunched the 'Deep Calming Mist' as part of its efforts to enhance product performance.

This content was produced with the assistance of AI translation services.